Nicotinamide Adenine Dinucleotide recalls
The FDA has published 2 recalls involving Nicotinamide Adenine Dinucleotide since 2018. The latest was reported on 20 Feb 2019. Most were for packaging defects. Promise Pharmacy has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 20 Feb 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why nicotinamide adenine dinucleotide is recalled
Companies
By year
All nicotinamide adenine dinucleotide recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nicotinamide Adenine Dinucleotide, 0.5 mg, injection vial recalled | Promise Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | Nicotinamide Adenine Dinucleotide 500 mg recalled | KRS Global Biotechnology | Packaging Defects | Nationwide |
Should you stop taking Nicotinamide Adenine Dinucleotide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.